News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ocular Sciences, Inc., USA Announces First Quarter 2004 Earnings Release Date And Conference Call



10/19/2005 5:10:52 PM

CONCORD, Calif., April 13 /PRNewswire-FirstCall/ -- Ocular Sciences, Inc. today announced that it will release financial results for the first quarter ended March 31, 2004 on Tuesday, May 4, 2004 at 4:00 p.m. EST. The Company will host a conference call and webcast on Tuesday, May 4, 2004 at 4:30 p.m. EST to discuss the Company's first quarter results, outlook for the remainder of the year and current corporate developments. The dial in number for the conference call is 800-218-0204 for domestic participants and 303-262-2175 for international participants.

A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will remain available through 12:00 Midnight EST on Tuesday, May 11, 2004 and can be accessed by dialing 800-405-2236 for domestic callers and 303-590-3000 for international callers, using the passcode 575778#. To access the live webcast of the call, go to Ocular's website at http://www.ocularsciences.com/ and click on the Investors icon. An archived webcast will also be available at http://www.ocularsciences.com/.

About Ocular Sciences, Inc.

Ocular Sciences, Inc. manufactures a broad line of high quality, competitively priced soft contact lenses marketed directly to eye-care practitioners. The Company's lenses are brand and product differentiated by distribution channel, and Ocular's unique lens technology makes thinner lenses that are easier to handle and more comfortable to wear than those of leading competitors.

Contacts: Investors Media EVC Group EVC Group Douglas Sherk Sheryl Seapy 415-896-6820 415-272-3323 Jennifer Beugelmans 415-896-6820

Ocular Sciences, Inc.

CONTACT: investors, Douglas Sherk, +1-415-896-6820, or JenniferBeugelmans, +1-415-896-6820; or media, Sheryl Seapy, +1-415-272-3323, all ofEVC Group, for Ocular Sciences, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES